ELMMB logo
Facebook logo Twitter logo
Drug Alerts and Withdrawals

Drug Alerts and Withdrawals

Drug Alerts and Withdrawals
 For more information about the MHRA click here 
 For MHRA Drug Safety Updates click here

When the MHRA, or occasionally another regulatory body in another country, such as the FDA, release advice, it is sometime necessary to produce additional local guidance.  This aims to be both clear and concise advice to healthcare professionals on the local action required to implement or respond to alerts issued by the MHRA or other bodies.  These memorandums are available below for reference, once they have been circulated to the relevant professionals in primary and secondary care:

MHRA News Stories.

 4th January 2022      MHRA Press Release Strong Steroid found in 'natural' skin cream. MHRA have issued a recall asking patients
                                     to return affected products.
11th Nov 2021           News Release Patient safety priority in recall of batches of cold and flu medicine with labelling error.
15th Sept 2021          MHRA Press Release The MHRA is advising anyone experiencing skin redness or burning sensations after
                                     they have stopped using these creams or ointments to seek advice from their health professional before
                                     using these products again.
 9th August 2021       MHRA Press Release MHRA recalls contaminated Irbesartan-batches as a precautionary measure. 
                                                                        Patients should not stop any treatments without consulting their doctor or pharmacist.
 8th July 2021             MHRA Press Release First progesterone-only contraceptive pills to be available to purchase from pharmacies      
 1st July 2021             Company led medicines recall: Morphine Syringe 50mg/50ml [unlicensed medicine] and Magnesium Sulphate
                                                                                         8mmol/20ml infusion [unlicensed medicine]
 17th June 2021         MHRA Press Release  MHRA recalls contaminated Irbesartan and Losartan batches as precautionary measure
 8th June 2021           MHRA Press Release  Over 3 million medicines and devices seized in UK as part of global crackdown
 28th May 2021         MHRA Press Release A personal trainer sentenced to 31 months in jail for selling and supplying unlicensed and                                                                                prescription medicines, together with Anabolic steroids, to the public.        
 4th May 2021           MHRA Press Release  MHRA announces appointment of Chief Safety Officer

MHRA Company-led Drug alerts

click here to access the most recent alerts

Items In This Category

application/pdfIbuprofen class 4 medicines defect information EL__20_A_30_FINAL july2020.pdf (125KB)22/07/2020Download
 Aspar Pharmaceuticals Limited has informed us that the Patient Information Leaflets (PILs) within the ibuprofen packs below are missing some information identified from post-marketing experience that... 
application/pdfDesmopressin nasal spray _all strengths_ Class 2 meds recall EL__20_A_29_FINAL150720.pdf (114KB)15/07/2020Download
 Ferring Pharmaceuticals Limited is recalling all unexpired stock of the above batches of products from pharmacies and wholesalers as a precautionary measure due to a lower volume of solution being... 
application/pdfNitrofurantoin 50mg tablets Class 2 medicines recall EL__20_A-28 150720.pdf (131KB)15/07/2020Download
 Dr Reddy's Laboratories (UK) Limited is recalling all unexpired stock of the above batch of Nitrofurantoin 50mg Tablets from pharmacies and wholesalers as a precautionary measure due to out of... 
application/pdfDepo-provera 150mg mL inj 1ml vial Cl 4 medicines defect info June 20 Final.pdf (104KB)30/06/2020Download
 Drugsrus Ltd (distributor) / Tenolol Ltd (MA Holder) has informed us of a typographical error in active ingredient stated on the label on the vial. The active ingredient should be... 
application/pdfEpistatus_Midazolam_10mg mL sol class 2 medicines recall EL__20_A_25_Final.pdf (92KB)09/06/2020Download
 Healthcare professionals are advised to stop supplying the above products immediately and quarantine all remaining stock and return it to your supplier using your supplier's approved process. 
application/pdfSodium Benzoate 2g in 10mL sol for inj Class 4 meds recall 280520 Final.pdf (48KB)28/05/2020Download
application/pdfEmerade 500mcg pfs class 2 medicines rceall 180520EL__20_A_23_Final.pdf (333KB)18/05/2020Download
application/pdfLevofloxacin 500mg tab class 4 meds recall 160420_Final.pdf (242KB)16/04/2020Download
 TEVA UK Limited has informed us that the Product Code/GTIN (PC) number found on the above batches is incorrect. The GTIN number that should have been allocated for this batch of tablets is... 
application/pdfEmerade 300mcg pen Class 2 meds recall EL__20_A_20_Final.pdf (340KB)09/04/2020Download
application/pdfEsmya 5mg Class 2 meds recallEL__20_A_16_Final.pdf (120KB)09/04/2020Download
application/pdfEmerade 150 mcg sol for inj Class 2 meds recal 0320_Final.pdf (348KB)05/03/2020Download
 Pharmaswiss ńĆeska republika s.r.o. (an affiliate of Bausch & Lomb UK Limited) is recalling all unexpired batches of Emerade 150 microgram auto-injectors (also referred to as pens) from patients due... 
application/pdfIbuprofen 400mg Class 4 Medicines recallEL__20_A_10_FInal__002_.pdf (173KB)21/02/2020Download
 Crescent Pharma Ltd and Flamingo Pharma (UK) Ltd have informed us that the Patient Information Leaflet (PIL) within their packs for the above pharmacy (P) batches is incorrect. The PIL in the above... 
Page: [1] [2] [3] [4] [5] [6] [7] [8] [9] [10]